Pharmacokinetic and Exposure-Response Modeling Support Body Surface Area-Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors.
Hayato S, Hamuro L, Shimizu T, Yonemori K, Nishio S, Yunokawa M, Yoshida T, Nishio M, Matsumoto K, Takehara K, Hasegawa K, Kozuki T, Hirashima Y, Kato H, Miura T, Nomoto M, Zhao Y, Zhu L, Yasuda S.
Hayato S, et al. Among authors: matsumoto k.
J Clin Pharmacol. 2025 Jan 24. doi: 10.1002/jcph.6187. Online ahead of print.
J Clin Pharmacol. 2025.
PMID: 39853764